Your browser doesn't support javascript.
loading
Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg.
Schröder, Valerie E; Skrozic, Amna; Erz, Dorothee; Kaysen, Anne; Fritz, Joëlle V; Loureiro, Joao M; McIntyre, Deborah; Pauly, Laure; Kemp, Jennifer; Schmitz, Sabine K; Wagner, Sophie; Reyes, Margarita; Soare, Ruxandra; Satagopam, Venkata; Vega, Carlos; Gawron, Piotr; Roomp, Kirsten; Conde, Patricia Martins; Klucken, Jochen; Köhler, Sebastian; Hartmann, Tobias; Dodel, Richard; Leist, Anja K; Kalbe, Elke; Krüger, Rejko.
  • Schröder VE; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Skrozic A; Department of Neurology, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg.
  • Erz D; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Kaysen A; Department of Neurology, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg.
  • Fritz JV; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Loureiro JM; Department of Neurology, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg.
  • McIntyre D; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Pauly L; Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
  • Kemp J; Department of Neurology, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg.
  • Schmitz SK; Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
  • Wagner S; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Reyes M; Department of Neurology, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg.
  • Soare R; Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
  • Satagopam V; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Vega C; Department of Geriatrics, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg.
  • Gawron P; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Roomp K; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Conde PM; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Klucken J; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Köhler S; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Hartmann T; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Dodel R; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Leist AK; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Kalbe E; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Krüger R; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
J Alzheimers Dis ; 97(2): 791-804, 2024.
Article en En | MEDLINE | ID: mdl-38189752
ABSTRACT

BACKGROUND:

With continuously aging societies, an increase in the number of people with cognitive decline is to be expected. Aside from the development of causative treatments, the successful implementation of prevention strategies is of utmost importance to reduce the high societal burden caused by neurodegenerative diseases leading to dementia among which the most common cause is Alzheimer's disease.

OBJECTIVE:

The aim of the Luxembourgish "programme dementia prevention (pdp)" is to prevent or at least delay dementia in an at-risk population through personalized multi-domain lifestyle interventions. The current work aims to provide a detailed overview of the methodology and presents initial results regarding the cohort characteristics and the implementation process.

METHODS:

In the frame of the pdp, an extensive neuropsychological evaluation and risk factor assessment are conducted for each participant. Based on the results, individualized multi-domain lifestyle interventions are suggested.

RESULTS:

A total number of 450 participants (Mean age = 69.5 years; SD = 10.8) have been screened at different recruitment sites throughout the country, among whom 425 participants (94.4%) met the selection criteria.

CONCLUSIONS:

We provide evidence supporting the feasibility of implementing a nationwide dementia prevention program and achieving successful recruitment of the target population by establishing a network of different healthcare providers.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Risk_factors_studies Límite: Aged / Humans País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Risk_factors_studies Límite: Aged / Humans País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article